Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes
- 1 February 1995
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 27 (2) , 133-140
- https://doi.org/10.1016/0168-8227(95)01026-a
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetesThe Lancet, 1993
- Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.Journal of Clinical Investigation, 1993
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Quantification of islet-cell antibodies and prediction of insulin-dependent diabetesThe Lancet, 1990
- FLUCTUATING ISLET-CELL AUTOIMMUNITY IN UNAFFECTED RELATIVES OF PATIENTS WITH INSULIN-DEPENDENT DIABETESThe Lancet, 1984
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983
- Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteinsNature, 1982
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975
- ANTIBODIES TO PANCREATIC ISLET CELLS IN INSULIN-DEPENDENT DIABETICS WITH COEXISTENT AUTOIMMUNE DISEASEThe Lancet, 1974
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974